FDA Inspection
GuerlainGuerlain – FDA Inspection, Apr 26, 2024
Record Details
This FDA Inspection record concerns Guerlain, with an inspection on April 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 02c68a05-3673-404e-8646-005e23f80957
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1237962
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)(4)Data secured in course of each test
- 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Guerlain
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Guerlain
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.